Dark

Check out our API

ESALY
EISAI CO S/ADR
stock OTC

Inactive

Jan 30, 2023

61.51USD-2.109%(-1.33)331,859

Pre-market

0.00USD-100.000%(-62.84)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 20, 2022

08:28AM EST The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug Benzinga

Dec 16, 2021

12:12PM EST Biogen Outlines Aduhelm's Confirmatory Trial Plans, Data Expected In 2026 Benzinga

Nov 30, 2021

04:02PM EST Europe Approves Merck-Eisai's Keytruda/Lenvima Combo Therapy For Endometrial Carcinoma Benzinga

Nov 11, 2021

12:58PM EST Eisai Posts New Lecanemab Data From Mid-Stage Alzheimer's Trial Benzinga

08:03AM EST The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts Benzinga

Nov 4, 2021

08:10AM EDT Safety Outcomes from the Lecanemab Phase 2b Study for Early Alzheimer's disease in Late-Breakers and Pipeline Updates at the Clinical Trials on Alzheimer's Disease (CTAD) Conference PR Newswire

Sep 28, 2021

09:19AM EDT Eisai, Biogen Initiate Rolling Submission For New Alzheimer's Drug Benzinga

08:18AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive Benzinga

08:16AM EDT The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK To Develop Long-Acting HIV Treatments Benzinga

Sep 10, 2021

07:35PM EDT Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential Benzinga

Sep 7, 2021

06:57AM EDT Dr Reddy's To Sell Its Anti-Cancer Agent To Citius Pharma Benzinga

Aug 31, 2021

08:15AM EDT The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical Benzinga

Aug 30, 2021

03:51PM EDT Amid Medicare Uncertainty, Biogen Offers Its Alzheimer's Drug For Free Benzinga

Aug 29, 2021

09:48AM EDT The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week Benzinga

Aug 20, 2021

04:37PM EDT White House Dismisses Janet Woodcock As Permanent FDA Commissioner Candidate: Bloomberg Benzinga

Aug 17, 2021

01:14PM EDT Controversial Aduhelm To Administered At More Than 300 Hospitals: Nikkei's Benzinga

Aug 15, 2021

12:16PM EDT The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow Benzinga

11:06AM EDT The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow Benzinga

Aug 12, 2021

08:09AM EDT The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma Benzinga

07:53AM EDT Biogen's New Alzheimer's Drug Turned Away By Veterans Affairs Benzinga

Aug 10, 2021

02:42PM EDT The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs Benzinga

Aug 2, 2021

06:10PM EDT Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates Benzinga

Jul 30, 2021

12:31PM EDT Biogen - Eisai Launch 5-Year Study To See How Well Alzheimer's Drug Aduhelm Works In Real World Benzinga

07:54AM EDT The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs Benzinga

Jul 27, 2021

06:30AM EDT Analysis Shows Biogen-Eisai's Aduhelm Slows Cognitive, Functional Decline In Early Alzheimer's Patients Benzinga

Jul 22, 2021

11:34AM EDT The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, Absci IPO Benzinga

07:41AM EDT Eisai Alzheimer's Disease Pipeline Research, Incl New Lecanemab Data, To Be Presented RTTNews

07:32AM EDT Data, to be Presented at 2021 Alzheimer's Association International Conference (AAIC) PR Newswire

Jul 15, 2021

10:51AM EDT Biogen's Alzheimer's Drug Aduhelm Review Could Have Been Handled Differently, Says FDA Chief: STAT News Benzinga

Jul 8, 2021

09:46AM EDT FDA Narrows Label To Recommend Use Of Biogen's Aduhelm In Mild Alzheimer's Patients Benzinga

Jun 24, 2021

08:12AM EDT The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO Benzinga

Jun 18, 2021

07:46AM EDT The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs Benzinga

07:05AM EDT Bristol Myers Inks Licensing Pact For Eisai's Folate Receptor ADC Drug, Lays Out Over $3B For Rights Benzinga

Jun 7, 2021

09:48AM EDT Merck/Eisai's Keytruda-Lenvima Combo Results in Better Health-Related Quality of Life Measures Compared to Sunitinib Benzinga

Jun 4, 2021

03:55PM EDT Ahead Of Judgement Day, FDA Faces Test with Biogen's Alzheimer's Drug Decision Benzinga

Jun 2, 2021

10:38AM EDT Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates Benzinga

May 7, 2021

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

Apr 23, 2021

07:28AM EDT The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs Benzinga

Mar 19, 2021

09:16AM EDT Merck' Keytruda Plus Eisai's Lenvima Cuts Risk Of Death By 38% In Endometrial Cancer Trial Compared To Chemo Benzinga

07:46AM EDT The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs Benzinga

Feb 16, 2021

01:19PM EST Merck/Eisai's Keytruda-Lenvima Combo Tops Standard Of Care In Late-Stage Kidney Cancer Study Benzinga

Jan 29, 2021

09:15AM EST Biogen Shares Jump After FDA Delays Aducanumab Decision By 3 Months Benzinga

Dec 10, 2020

07:42AM EST The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations Benzinga

05:48AM EST Biogen Filed NDA for Aducanumab in Japan Benzinga

Nov 11, 2020

07:38AM EST The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap Benzinga

Oct 30, 2020

08:09AM EDT The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts Benzinga

Sep 25, 2020

05:20AM EDT Gilead Announced Jyseleca Approved in Japan for Rheumatoid Arthritis Benzinga

Sep 20, 2020

08:34AM EDT Merck, Eisai Present First-Time Data From Two Studies Evaluating KEYTRUDA Plus LENVIMA in Seven Different Tumor Types at ESMO 2020 Benzinga

Aug 3, 2020

04:13AM EDT Earnings Scheduled For August 3, 2020 Benzinga

Jul 14, 2020

05:37AM EDT Biogen Announces Initiation Of New Phase III Clinical Study (AHEAD 3-45) Of BAN2401 Preclinical (Asymptomatic) Alzheimer's Disease Benzinga

Share